CompletedNot applicableNCT07240142

Neurotransmitter Levels in Children With Specific Learning Disorder

Studying Specific learning disability

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Dilara Ulger Ozbek
Principal Investigator
Dilara ULGER OZBEK, Dr.
Cumhuriyet University
Intervention
Blood Product(procedure)
Enrollment
40 target
Eligibility
7-14 years · All sexes
Timeline
20192021

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07240142 on ClinicalTrials.gov

Other trials for Specific learning disability

Additional recruiting or active studies for the same condition.

See all trials for Specific learning disability

← Back to all trials